Journal of Biological Chemistry · 2007 · 61 citations · 38 references
Life SciencesBiochemistryMolecular BiologyCell SignalingMolecular PhysiologyStructural BiologyCardiac Ion ChannelsChannel StructureIon Channel RegulationProtein PhosphorylationProtein StructureReceptor PhysiologyCalcium-dependent Protein Kinase IiCalmodulin SignalingCalmodulin-dependent Protein Kinase IiCardiac Ion Channel RegulationIon Channel PhosphorylationPhosphorylation Site MappingReceptor AutophosphorylationRyanodine Receptors
Type 2 ryanodine receptor (RyR2) is the major calcium release channel in cardiac muscle. Phosphorylation of RyR2 by cAMP-dependent protein kinase A and by calmodulin-dependent protein kinase II modulates channel activity. Hyperphosphorylation at a single amino acid residue, Ser-2808, has been proposed to directly disrupt the binding of a 12.6-kDa FK506-binding protein (FKBP12.6) to RyR2, causing a RyR2 malfunction that triggers cardiac arrhythmias in human heart failure. To determine the structural basis of the interaction between Ser-2808 and FKBP12.6, we have employed two independent approaches to map this phosphorylation site in RyR2 by three-dimensional cryo-electron microscopy. In one approach, we inserted a green fluorescent protein (GFP) after amino acid Tyr-2801, and mapped the GFP three-dimensional location in the RyR2 structure. In another approach, the binding site of monoclonal antibody 34C was mapped in the three-dimensional structure of skeletal muscle RyR1. The epitope of antibody 34C has been mapped to amino acid residues 2,756 through 2,803 of the RyR1 sequence, corresponding to residues 2,722 through 2,769 of the RyR2 sequence. These locations of GFP insertion and antibody binding are adjacent to one another in domain 6 of the cytoplasmic clamp region. Importantly, the three-dimensional location of the Ser-2808 phosphorylation site is 105-120Å distance from the FKBP12.6 binding site mapped previously, indicating that Ser-2808 is unlikely to be directly involved in the binding of FKBP12.6 to RyR2, as had been proposed previously. Type 2 ryanodine receptor (RyR2) is the major calcium release channel in cardiac muscle. Phosphorylation of RyR2 by cAMP-dependent protein kinase A and by calmodulin-dependent protein kinase II modulates channel activity. Hyperphosphorylation at a single amino acid residue, Ser-2808, has been proposed to directly disrupt the binding of a 12.6-kDa FK506-binding protein (FKBP12.6) to RyR2, causing a RyR2 malfunction that triggers cardiac arrhythmias in human heart failure. To determine the structural basis of the interaction between Ser-2808 and FKBP12.6, we have employed two independent approaches to map this phosphorylation site in RyR2 by three-dimensional cryo-electron microscopy. In one approach, we inserted a green fluorescent protein (GFP) after amino acid Tyr-2801, and mapped the GFP three-dimensional location in the RyR2 structure. In another approach, the binding site of monoclonal antibody 34C was mapped in the three-dimensional structure of skeletal muscle RyR1. The epitope of antibody 34C has been mapped to amino acid residues 2,756 through 2,803 of the RyR1 sequence, corresponding to residues 2,722 through 2,769 of the RyR2 sequence. These locations of GFP insertion and antibody binding are adjacent to one another in domain 6 of the cytoplasmic clamp region. Importantly, the three-dimensional location of the Ser-2808 phosphorylation site is 105-120Å distance from the FKBP12.6 binding site mapped previously, indicating that Ser-2808 is unlikely to be directly involved in the binding of FKBP12.6 to RyR2, as had been proposed previously. Sudden cardiac death (SCD) 2The abbreviations used are:SCDsudden cardiac deathARVD2arrhythmogenic right ventricular dysplasia type 2CPVTcatecholaminergic polymorphic ventricular tachycardiaEMelectron microscopyFKBP12.612.6-kDa FK506-binding proteinGFPgreen fluorescent proteinmAb34Cmonoclonal antibody 34CPKAcAMP-dependent protein kinaseRyRryanodine receptorRyR1 and RyR2type 1 (skeletal) RyR and type 2 (cardiac) RyR respectivelywtwild typePIPES1,4-piperazinediethanesulfonic acidCHAPS3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonic acid. 2The abbreviations used are:SCDsudden cardiac deathARVD2arrhythmogenic right ventricular dysplasia type 2CPVTcatecholaminergic polymorphic ventricular tachycardiaEMelectron microscopyFKBP12.612.6-kDa FK506-binding proteinGFPgreen fluorescent proteinmAb34Cmonoclonal antibody 34CPKAcAMP-dependent protein kinaseRyRryanodine receptorRyR1 and RyR2type 1 (skeletal) RyR and type 2 (cardiac) RyR respectivelywtwild typePIPES1,4-piperazinediethanesulfonic acidCHAPS3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonic acid. is a sudden, unexpected death caused by loss of heart function. SCD is the leading cause of natural death in the United States, producing about 330,000 deaths each year (1 American Heart Association, Heart Disease and Stroke Statistics, Dallas, TX2007Google Scholar). SCD occurs when the electrical system in the heart malfunctions, leading to fatal arrhythmias. Most cases of SCD can be explained by cardiovascular abnormalities identifiable at autopsy, but some SCD is associated with structurally normal hearts (2Tester D.J. Spoon D.B. Valdivia H.H. Makielski J.C. Ackerman M.J. Mayo Clin. Proc. 2004; 79: 1380-1384Abstract Full Text Full Text PDF PubMed Scopus (237) Google Scholar). In some such cases, abnormal calcium release through a dysfunctional cardiac muscle ryanodine receptor (type 2 RyR, or RyR2) has been implicated, and molecular genetic analysis has demonstrated that mutations in the RyR2 gene can be linked to about 14% of these structurally normal heart SCD cases (2Tester D.J. Spoon D.B. Valdivia H.H. Makielski J.C. Ackerman M.J. Mayo Clin. Proc. 2004; 79: 1380-1384Abstract Full Text Full Text PDF PubMed Scopus (237) Google Scholar). sudden cardiac death arrhythmogenic right ventricular dysplasia type 2 catecholaminergic polymorphic ventricular tachycardia electron microscopy 12.6-kDa FK506-binding protein green fluorescent protein monoclonal antibody 34C cAMP-dependent protein kinase ryanodine receptor type 1 (skeletal) RyR and type 2 (cardiac) RyR respectively wild type 1,4-piperazinediethanesulfonic acid 3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonic acid. sudden cardiac death arrhythmogenic right ventricular dysplasia type 2 catecholaminergic polymorphic ventricular tachycardia electron microscopy 12.6-kDa FK506-binding protein green fluorescent protein monoclonal antibody 34C cAMP-dependent protein kinase ryanodine receptor type 1 (skeletal) RyR and type 2 (cardiac) RyR respectively wild type 1,4-piperazinediethanesulfonic acid 3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonic acid. RyR2 functions as a calcium release channel in the heart, where it plays a crucial role in excitation-contraction coupling. To date, more than 60 naturally occurring mutations in RyR2 have been linked to two genetic forms of ventricular arrhythmias: catecholaminergic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventricular dysplasia type 2 (ARVD2; Refs. 2Tester D.J. Spoon D.B. Valdivia H.H. Makielski J.C. Ackerman M.J. Mayo Clin. Proc. 2004; 79: 1380-1384Abstract Full Text Full Text PDF PubMed Scopus (237) Google Scholar, 3Priori S.G. Napolitano C. Tiso N. Memmi M. Vignati G. Bloise R. Sorrentino V. Danieli G.A. Circulation. 2001; 103: 196-200Crossref PubMed Scopus (1125) Google Scholar, 4Laitinen P.J. Brown K.M. Piippo K. Swan H. Devaney J.M. Brahmbhatt B. Donarum E.A. Marino M. Tiso N. Viitasalo M. Toivonen L. Stephan D.A. Kontula K. Circulation. 2001; 103: 485-490Crossref PubMed Scopus (608) Google Scholar, 5Priori S.G. Napolitano C. Memmi M. Colombi B. Drago F. Gasparini M. DeSimone L. Coltorti F. Bloise R. Keegan R. Cruz Filho F.E.S. Vignati G. Benatar A. DeLogu A. Circulation. 2002; 106: 69-74Crossref PubMed Scopus (924) Google Scholar, 6Choi G. Kopplin L.J. Tester D.J. Will M.L. Haglund C.M. Ackerman M.J. Circulation. 2004; 110: 2119-2124Crossref PubMed Scopus (197) Google Scholar). These mutations are largely clustered in three regions of the RyR2 amino acid sequence: region 1 is near the N terminus, from residues 77 to 466; region 2 is near the middle of the sequence, spanning residues 1,724 through 2,958; and region 3 includes both cytoplasmic and membrane-associated regions of the sequence and comprises residues 3,778 through 4,959. Intriguingly, the same three regions are homologous to the three malignant hyperthermia and central core disease mutation regions in skeletal isoform RyR (type 1 RyR or RyR1, Ref. 7McCarty T.V. Quane K.A. Lynch P.J. Hum. Mutat. 2000; 15: 410-417Crossref PubMed Scopus (299) Google Scholar), suggesting that the three regions represent structural domains critical for the regulation of both RyR1 and RyR2, and suggesting also that the molecular pathologies underlying these RyR-linked skeletal and cardiac muscle diseases involve similar mechanisms. The causal relationships among RyR2 mutations, the abnormal Ca2+ release function, and physiological manifestation is under investigation. Some mechanisms underlying RyR2 channel dysfunction in SCD have been proposed, including channel instability because of destabilization of the RyR2-FKBP12.6 interaction (8Marx S.O. Reiken S. Hisamatsu Y. Jayaraman T. Burkhoff D. Rosemblit N. Marks A.R. Cell. 2000; 101: 365-376Abstract Full Text Full Text PDF PubMed Scopus (1653) Google Scholar, 9Wehrens X.H.T. Lehnart S.E. Huang F. Vest J.A. Reiken S.R. P.J. S. Rosemblit N. J.M. Napolitano C. Memmi M. S.G. Marks A.R. Cell. Full Text Full Text PDF PubMed Scopus Google or interaction N. T. 2002; PubMed Google Scholar, H. N. PubMed Scopus Google for Ca2+ release D. B. D. R. L. H. Proc. S. A. 2004; 101: PubMed Scopus Google channel to cytoplasmic calcium PubMed Scopus Google and S.E. X.H.T. P.J. Reiken S.R. Kontula K. Swan H. Marks A.R. Circulation. 2004; PubMed Scopus Google Scholar). is that is and involved in and FKBP12.6, to RyR1 and RyR2, and are to be of RyR T. S. H. Marks A.R. Full Text PDF PubMed Google Scholar, L. L. K. S. 2001; PubMed Scopus Google Scholar). and FKBP12.6 have been to the of the RyR1 and RyR2 Ca2+ channel K. A. Jayaraman T. M. Marks A.R. Cell. Full Text PDF PubMed Scopus Google Scholar, Marks A.R. PubMed Scopus Google Scholar). (8Marx S.O. Reiken S. Hisamatsu Y. Jayaraman T. Burkhoff D. Rosemblit N. Marks A.R. Cell. 2000; 101: 365-376Abstract Full Text Full Text PDF PubMed Scopus (1653) Google have that protein kinase A phosphorylation of RyR2 FKBP12.6 and the channel and that of RyR2 at a single amino acid RyR2 sequence, corresponding to Ser-2808 in to channel in X.H.T. Lehnart S.E. Huang F. Vest J.A. Reiken S.R. P.J. S. Rosemblit N. J.M. Napolitano C. Memmi M. S.G. Marks A.R. Cell. Full Text Full Text PDF PubMed Scopus Google have that mutations in RyR2 and the binding of FKBP12.6 for RyR2, and the channel that can fatal cardiac arrhythmias under and the mechanisms proposed by and are with Y. G.A. 2002; PubMed Scopus Google of phosphorylation of the RyR2 calcium in ventricular Valdivia H.H. 2002; PubMed Scopus Google of FKBP12.6 from RyR2 in cardiac with M. L. D. N. G. Full Text Full Text PDF PubMed Scopus Google of RyR2 at or and that FKBP12.6 binding channel B. C. 2004; PubMed Scopus Google that FKBP12.6 can to both the Ser-2808 and forms of RyR2, and that a the to phosphorylation at Ser-2808 by disrupt the PubMed Scopus Google have demonstrated that RyR2 mutations Ca2+ the RyR2-FKBP12.6 The binding for and FKBP12.6 have been mapped in the three-dimensional of RyR1 and RyR2, respectively T. M. R. S. Full Text Full Text PDF PubMed Scopus Google Scholar, S. T. Full Text Full Text PDF PubMed Scopus Google Scholar). the phosphorylation site Ser-2808 in the RyR three-dimensional has been that a structural to the Ser-2808 in the three-dimensional structure of RyR is to the proposed FKBP12.6 we have mapped two mutation in the three-dimensional structure of RyR2 by green fluorescent protein (GFP) at amino acid with cryo-electron microscopy and R. T. Full Text Full Text PDF PubMed Scopus Google Scholar, R. S. T. Full Text Full Text PDF PubMed Scopus Google Scholar), these some structural the of RyR2 In the we employed the same structural to determine the Ser-2808 phosphorylation site in the three-dimensional structure of RyR, directly the of FKBP12.6 that was proposed by Marks and have used two independent approaches to the three-dimensional location of the phosphorylation In the approach, we inserted GFP after amino acid Tyr-2801, and mapped three-dimensional location in the RyR2 structure. In the approach, the binding site of monoclonal antibody 34C was mapped in the three-dimensional structure of RyR1. The epitope of the 34C antibody has been to amino acid residues 2,756 through 2,803 of RyR1, corresponding to residues 2,722 through 2,769 of RyR2 H. N. S. T.V. Full Text Full Text PDF PubMed Scopus Google Scholar). that the mapped GFP insertion site and the antibody binding site are adjacent to one another in domain 6 of the cytoplasmic clamp region. site is to the FKBP12.6 binding site mapped previously. of and mutation was the RyR2 as R. H. L. Brown C. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). To the the the was by a and was by as T. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). site was after by The and The The the GFP and the was the after to the and in as K. L. Full Text Full Text PDF PubMed Scopus Google Scholar). in for after with of or Ca2+ and of and for after three with and in the same by for at in The in a and a 2 and and for 1 was by at in a at for and the and to the of protein to the and the was at with for 2 The by and with and The RyR2 from the by with in 1 and for The was in and at Ca2+ and of Ca2+ in the was with the Ca2+ as K. L. Full Text Full Text PDF PubMed Scopus Google Scholar). binding to was as Full Text Full Text PDF PubMed Scopus Google Scholar). and and to and by antibody and antibody as T. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). of the green of in a and with as after the three with a and with a fluorescent a and was to was from of by protein A the as by the from by To the binding of a was of with and of with or of RyR1, for at and the two and for a The protein and by of RyR1 and of RyR1 was from from skeletal muscle as M. A. S. Full Text PDF PubMed Google Scholar). The RyR1 by of to RyR1 with a RyR and for and for by electron at with The of the was at The of the between and at a of To more of the RyR we the between and to electron of for and the of by electron a with a of the M. Y. M. A. PubMed Scopus Google Scholar). each was to one of a of after the of and for each for both the RyR1 and the RyR1 A of was by the RyR1 and RyR1 to the binding The from the RyR1 to a the and to a the by the Ref. of Google Scholar). from the in the from of in through a M. T. Proc. S. A. 2001; PubMed Scopus Google Scholar). The three-dimensional of RyR1, and the RyR1 from and that the the and that each be by of was in three-dimensional The to be by the with a of A. R. N. PubMed Scopus Google for both and and for both RyR1 and the RyR1 and of and have that mutation in the of RyR2, a channel and a to by R. H. L. Brown C. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). These that the mutation the of the that such a channel be to the channel for structural we that the protein can be and by as and is structural between the and the RyR2 was used as the for structural To determine the location of the phosphorylation Ser-2808, in the three-dimensional structure of RyR2, GFP was inserted after in the The was in in by green indicating of the inserted To determine functions as a Ca2+ release we Ca2+ the fluorescent Ca2+ in with or in with Ca2+ release in to by a RyR the of ryanodine to a to from of the channel by is to to the of the and to the channel a of the channel to T. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). These that is to and ryanodine Importantly, the Ca2+ release of to and ryanodine similar to for the and similar Ca2+ of binding The for Ca2+ of and are and These that the protein and channel function. The and from by with used as the T. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). The protein was by and A single molecular at a than the to the of was in the of was by both the and the the protein was by the antibody of and to a to and and by electron microscopy. A and electron in and are of these RyR M. V. R. S. T. PubMed Scopus Google Scholar). was the M. Y. M. A. PubMed Scopus Google Scholar). by a M. T. Proc. S. A. 2001; PubMed Scopus Google Scholar). and of the three-dimensional of and in three both the structure of two major a cytoplasmic of at domains by Refs. M. V. R. S. T. PubMed Scopus Google and M. T. PubMed Scopus Google Scholar), and a both of the the was to be the with as the A. R. N. PubMed Scopus Google Scholar). the two three-dimensional are but are some The was in the region between domains and the of the domains and 6 of to be than the corresponding in in To more the we a three-dimensional map by the of from that of The regions in green and the three-dimensional of map one in each domains and 6 in the cytoplasmic GFP was inserted each RyR2 because RyR2 is a of the is to in the three-dimensional are that the in the map the by the GFP insertion in because it is the that is when the three-dimensional map is with the same as we used to the and or was the of one of the in to a molecular of a protein of this with the molecular of GFP M. V. R. S. T. PubMed Scopus Google Scholar). at a are with the inserted GFP in of or In Tyr-2801, as by the inserted is in the between domains and in each of the regions of of the approach, we the binding site of a sequence monoclonal skeletal isoform RyR1 is antibody that is and is used to RyR in it three of The epitope of has been to involve amino acid residues 2,756 through 2,803 of RyR1, corresponding to residues 2,722 through 2,769 of RyR2 H. N. S. T.V. Full Text Full Text PDF PubMed Scopus Google Scholar), about amino acid residues from the RyR2 phosphorylation site The sequence and three-dimensional structure are between RyR1 and RyR2, and the binding site of in RyR1 is in the same region as is the FKBP12.6 binding site in RyR2 T. M. R. S. Full Text Full Text PDF PubMed Scopus Google Scholar, S. T. Full Text Full Text PDF PubMed Scopus Google Scholar). through of the three-dimensional locations of the binding site and the binding we be to the of interaction between and the phosphorylation A was to of was from and from by used of in single because one has two and two RyR The and by the of are in the one at and the at These are with the molecular of the and of is one in the corresponding to the and the was in indicating that both the and are The binding of the was by with RyR1. protein to RyR1, but to was with or RyR1 with and it was by the and by that in the of RyR1 1 and the was by and but it was in the of RyR1 3 and that the of can to RyR1 The with RyR1 for the RyR1 and RyR1 by A and electron in of RyR1 and are A in this is that among the more than receptor that for of the three-dimensional of RyR1 some have than the of is a and has binding with that for the GFP insertion approach, in of GFP is inserted that of RyR2, and of the have the GFP insertion In the antibody approach, the binding between RyR1 and is to be in the a of RyR1 are to be of A binding of 1 that of RyR1 are to under To the of RyR1 that are to we a analysis by a Ref. of Google at the of to the of this that about of the RyR1 have RyR1 have Most of the RyR1 from the in the this is for we that a of RyR1 from in the than of the of the three-dimensional is from a to is and in at of and of the three-dimensional of RyR1 and the RyR1 in three The was to be the two three-dimensional are also the in domain as in the in the two by where domain 6 of the RyR1 at a three-dimensional map by the of the RyR1 from the of the RyR1 The in are the three-dimensional of RyR1 map that is one RyR1 at the of domain FKBP12.6 to cardiac muscle RyR2, and is to RyR2 channel by the of the and by between and Ref. L. L. K. S. 2001; PubMed Scopus Google Scholar). A homologous to skeletal muscle RyR1 and RyR1 in a similar K. A. Jayaraman T. M. Marks A.R. Cell. Full Text PDF PubMed Scopus Google Scholar). of from RyR by or channel of and calcium Marks A.R. PubMed Scopus Google Scholar). The Marks (8Marx S.O. Reiken S. Hisamatsu Y. Jayaraman T. Burkhoff D. Rosemblit N. Marks A.R. Cell. 2000; 101: 365-376Abstract Full Text Full Text PDF PubMed Scopus (1653) Google has proposed that of a amino in RyR2, FKBP12.6, and that such a RyR2 to the ventricular arrhythmias that heart failure. In a from the same it was proposed that FKBP12.6 occurs through between the at of RyR2 and a residue, of FKBP12.6 near the binding X.H.T. Lehnart S.E. Huang F. Vest J.A. Reiken S.R. P.J. S. Rosemblit N. J.M. Napolitano C. Memmi M. S.G. Marks A.R. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar). in RyR2 that cause and are to the of RyR2 for FKBP12.6 X.H.T. Lehnart S.E. Huang F. Vest J.A. Reiken S.R. P.J. S. Rosemblit N. J.M. Napolitano C. Memmi M. S.G. Marks A.R. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar). a of the interaction at was proposed as a for cardiac muscle dysfunction in sudden cardiac death and heart failure. the proposed mechanisms are with Y. G.A. 2002; PubMed Scopus Google Scholar, Valdivia H.H. 2002; PubMed Scopus Google Scholar, M. L. D. N. G. Full Text Full Text PDF PubMed Scopus Google Scholar, B. C. 2004; PubMed Scopus Google Scholar, PubMed Scopus Google Scholar), and to the of that the that at Ser-2808 in in RyR2 of The and FKBP12.6 binding mapped to the same region in the three-dimensional of RyR1 and RyR2, at or near the of domains 3 and in and Refs. T. M. R. S. Full Text Full Text PDF PubMed Scopus Google and S. T. Full Text Full Text PDF PubMed Scopus Google Scholar). In the we used two independent approaches to two regions the RyR2 amino acid sequence that are near the phosphorylation site in the three-dimensional structure of The GFP insertion at Tyr-2801, is amino acid residues of Ser-2808, is in the between domains and 6 in The binding site for the from monoclonal antibody epitope is about amino acid residues from Ser-2808, is in domain 6 in These two are adjacent to one another in each of the clamp in the RyR cytoplasmic and to is about The three-dimensional location of the phosphorylation site Ser-2808 is also to a mapped mutation site at is in the between domains and 6 in Ref. R. T. Full Text Full Text PDF PubMed Scopus Google Scholar). the GFP to be the of the of Ser-2808 in the three-dimensional structure of RyR, we that Ser-2808 is to the binding site of the structure of RyR phosphorylation and FKBP12.6 binding we the two FKBP12.6 binding that are to the phosphorylation as in the FKBP12.6 binding site in the same clamp region is about from the Ser-2808 the one in the adjacent clamp regions is about In both skeletal and cardiac at the of the can phosphorylation of a Ser-2808 in one RyR disrupt the binding of FKBP12.6 to a RyR in the C. F. C. 2004; PubMed Scopus Google have the of the of RyR, and we have three-dimensional of Ser-2808 and FKBP12.6 binding site structural in the distance between the phosphorylation site Ser-2808 the of and the FKBP12.6 binding site in the RyR In to the structural we have two of to that the phosphorylation site Ser-2808 is to the binding in the of we used protein as the binding The that the insertion of GFP near Ser-2808 the binding of FKBP12.6 to in the of we used with to the RyR1 The that the binding of with the binding of The site of the GFP insertion is amino acid residues from Ser-2808 in the sequence, but the distance between the GFP site and the FKBP12.6 binding location as by three-dimensional is with the that the phosphorylation site is directly involved in the binding of have also about the role of this phosphorylation site in the A analysis demonstrated that a region between residues and near region is for FKBP12.6 interaction H. R. D. F. T. Full Text Full Text PDF PubMed Scopus Google Scholar). with this we used to map a GFP insertion at the middle of region to domain a adjacent to the FKBP12.6 binding site H. R. D. F. T. Full Text Full Text PDF PubMed Scopus Google Scholar). In to the (8Marx S.O. Reiken S. Hisamatsu Y. Jayaraman T. Burkhoff D. Rosemblit N. Marks A.R. Cell. 2000; 101: 365-376Abstract Full Text Full Text PDF PubMed Scopus (1653) Google Scholar, 9Wehrens X.H.T. Lehnart S.E. Huang F. Vest J.A. Reiken S.R. P.J. S. Rosemblit N. J.M. Napolitano C. Memmi M. S.G. Marks A.R. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar), have that phosphorylation of Ser-2808 in RyR2 in of FKBP12.6, because FKBP12.6 can to both the Ser-2808 and forms of RyR2 B. C. 2004; PubMed Scopus Google Scholar). with the mutation or at this phosphorylation site also the to FKBP12.6 M. L. D. N. G. Full Text Full Text PDF PubMed Scopus Google Scholar). RyR2 is to be at Ser-2808 by and and at by Phosphorylation of RyR2 at these residues modulates the of the is about the structural basis of regulation of RyR2 by that the phosphorylation that the Ser-2808 and is from the FKBP12.6 binding the that the phosphorylation of RyR2 at Ser-2808 directly the binding of FKBP12.6, causing from the as proposed previously. the it is of to that the three-dimensional location of the Ser-2808 site is to a mapped site in the central mutation in Ref. R. T. Full Text Full Text PDF PubMed Scopus Google Scholar), suggesting that the of phosphorylation the of RyR2 be similar to that of the are three mutation in the RyR2 sequence that mutations, region 1 is near the N of the from residues 77 to 466; region 2 is near the middle of the sequence, spanning residues 1,724 through 2,958; and region 3 includes of the and membrane-associated regions of the channel and comprises residues 3,778 to 4,959. mutation in the cytoplasmic regions of RyR2, the region and the central and are in the sequence amino to the proposed by and N. T. 2002; PubMed Google Scholar), these two regions in structural domains that with each another in the three-dimensional and in the of interaction to mutations can channel the between the and central regions RyR in the and in the of the interaction of these regions and causing RyR to more In of this we have mapped a mutation in the region a region between domains and R. S. T. Full Text Full Text PDF PubMed Scopus Google Scholar), and a mutation in the central region to a site between domains and 6 R. T. Full Text Full Text PDF PubMed Scopus Google Scholar). These that the mutations are in domain the central mutations are in domain and that are between to the RyR channel R. S. T. Full Text Full Text PDF PubMed Scopus Google Scholar). the three-dimensional location of the Ser-2808 phosphorylation site is near to the it is that at Ser-2808 the between the and the central regions of RyR2, and the of the In is to the that at Ser-2808 of FKBP12.6 from RyR2 a between the at Ser-2808 and the of the interaction by this have to such as a distance of of a or by one or more RyR including Ca2+ and and protein protein and the and and the for of of
38
PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)
Steven O. Marx, Steven Reiken, Yuji Hisamatsu et al. · Cell · 2000 · 2K citations · Full text